AI assistant
Sending…
Aura Biosciences, Inc. — Director's Dealing 2021
Oct 29, 2021
33080_dirs_2021-10-29_7836b1bd-0c91-4efa-8912-5e315ba06552.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28
Reporting Person: Johnson David Michael (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-28 | Stock Option (Right to Buy) | $14.00 | A | 24000 | Acquired | 2031-10-27 | Common Stock (24000) | Direct |
Footnotes
F1: The shares underlying this option vest as follows: These shares will vest in full on October 28, 2022.